![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 8, 4607-4612, February 19, 1999
From the Department of Biological Chemistry, Weizmann Institute of
Science, Rehovot 76100, Israel
In a previous study we observed that long term (5 days) incubation with fumonisin B1 (FB1),
an inhibitor of acylation of sphingoid long chain bases to
(dihydro)ceramide, resulted in morphological and biochemical
changes in 3T3 fibroblasts (Meivar-Levy, I., Sabanay, H., Bershadsky,
A. D., and Futerman, A. H. (1997) J. Biol.
Chem. 272, 1558-1564). Among these were changes in the profile
of synthesis of sphingolipids (SLs) and glycosphingolipids (GSLs).
Whereas [3H]globotriaosylceramide
([3H]Gb3) comprised 1.9% of the total
[3H]SLs and [3H]GSLs synthesized in control
cells, it comprised 16.5% in FB1-treated cells. We now
demonstrate by in vitro analysis that inhibition of
ceramide synthesis by FB1 for 5 days results in
up-regulation of the activities of three enzymes in the pathway of
Gb3 synthesis, namely glucosylceramide, lactosylceramide,
and Gb3 synthases; up-regulation is due to an increase in
Vmax, with no change in Km
values toward lipid substrates. Moreover, molecular analysis (reverse
transcriptase-polymerase chain reaction) of glucosylceramide synthase
indicated that this enzyme is up-regulated at the transcriptional
level. No changes in either the Vmax or Km values of sphingomyelin or of GM3
synthase were detected after FB1 treatment. Analysis of SL
and GSL synthesis in cultured cells using
[4,5-3H]sphinganine as a metabolic precursor demonstrated
that at low substrate concentrations, Gb3 synthesis is
favored over GM3 synthesis and glucosylceramide synthesis
is favored over sphingomyelin synthesis, whereas the opposite is true
at high substrate concentrations. These data demonstrate that GSL
synthesis and in particular Gb3 synthesis are tightly
regulated in fibroblasts, presumably so as to maintain constant levels
of Gb3 on the cell surface.
This article has been cited by other articles:
![]() |
S. Mebarek, H. Komati, F. Naro, C. Zeiller, M. Alvisi, M. Lagarde, A.-F. Prigent, and G. Nemoz Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation J. Cell Sci., February 1, 2007; 120(3): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. He, H. Suzuki, N. Sharma, and R. P. Sharma Ceramide Synthase Inhibition by Fumonisin B1 Treatment Activates Sphingolipid-Metabolizing Systems in Mouse Liver Toxicol. Sci., December 1, 2006; 94(2): 388 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Taranu, D. E. Marin, S. Bouhet, F. Pascale, J.-D. Bailly, J. D. Miller, P. Pinton, and I. P. Oswald Mycotoxin Fumonisin B1 Alters the Cytokine Profile and Decreases the Vaccinal Antibody Titer in Pigs Toxicol. Sci., April 1, 2005; 84(2): 301 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C.D. van IJzendoorn, J. M. van der Wouden, G. Liebisch, G. Schmitz, and D. Hoekstra Polarized Membrane Traffic and Cell Polarity Development Is Dependent on Dihydroceramide Synthase-Regulated Sphinganine Turnover Mol. Biol. Cell, September 1, 2004; 15(9): 4115 - 4124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis J. Biol. Chem., February 27, 2004; 279(9): 7867 - 7876. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Oswald, C. Desautels, J. Laffitte, S. Fournout, S. Y. Peres, M. Odin, P. Le Bars, J. Le Bars, and J. M. Fairbrother Mycotoxin Fumonisin B1 Increases Intestinal Colonization by Pathogenic Escherichia coli in Pigs Appl. Envir. Microbiol., October 1, 2003; 69(10): 5870 - 5874. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Viani, P. Giussani, L. Brioschi, R. Bassi, V. Anelli, G. Tettamanti, and L. Riboni Ceramide in Nitric Oxide Inhibition of Glioma Cell Growth. EVIDENCE FOR THE INVOLVEMENT OF CERAMIDE TRAFFIC J. Biol. Chem., March 7, 2003; 278(11): 9592 - 9601. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prinetti, L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al. Altered Sphingolipid Metabolism in N-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells J. Biol. Chem., February 14, 2003; 278(8): 5574 - 5583. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venkataraman, C. Riebeling, J. Bodennec, H. Riezman, J. C. Allegood, M. C. Sullards, A. H. Merrill Jr., and A. H. Futerman Upstream of Growth and Differentiation Factor 1 (uog1), a Mammalian Homolog of the Yeast Longevity Assurance Gene 1 (LAG1), Regulates N-Stearoyl-sphinganine (C18-(Dihydro)ceramide) Synthesis in a Fumonisin B1-independent Manner in Mammalian Cells J. Biol. Chem., September 13, 2002; 277(38): 35642 - 35649. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Boldin and A. H. Futerman Up-regulation of Glucosylceramide Synthesis upon Stimulation of Axonal Growth by Basic Fibroblast Growth Factor. EVIDENCE FOR POST-TRANSLATIONAL MODIFICATION OF GLUCOSYLCERAMIDE SYNTHASE J. Biol. Chem., March 31, 2000; 275(14): 9905 - 9909. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lala, S. Ito, and C. A. Lingwood Retroviral Transfection of Madin-Darby Canine Kidney Cells with Human MDR1 Results in a Major Increase in Globotriaosylceramide and 105- to 106-Fold Increased Cell Sensitivity to Verocytotoxin. ROLE OF P-GLYCOPROTEIN IN GLYCOLIPID SYNTHESIS J. Biol. Chem., February 25, 2000; 275(9): 6246 - 6251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Chalfant, B. Ogretmen, S. Galadari, B.-J. Kroesen, B. J. Pettus, and Y. A. Hannun FAS Activation Induces Dephosphorylation of SR Proteins. DEPENDENCE ON THE DE NOVO GENERATION OF CERAMIDE AND ACTIVATION OF PROTEIN PHOSPHATASE 1 J. Biol. Chem., November 21, 2001; 276(48): 44848 - 44855. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |